Pop Pulse News

Stifel Canada Analysts Lower Earnings Estimates for Sylogist


Stifel Canada Analysts Lower Earnings Estimates for Sylogist

Sylogist Ltd. (TSE:SYZ - Free Report) - Stifel Canada decreased their FY2024 earnings per share (EPS) estimates for shares of Sylogist in a research note issued to investors on Thursday, November 7th. Stifel Canada analyst S. Sukumar now forecasts that the company will post earnings per share of $0.20 for the year, down from their previous forecast of $0.26. The consensus estimate for Sylogist's current full-year earnings is $0.24 per share. Stifel Canada also issued estimates for Sylogist's Q4 2024 earnings at $0.06 EPS.

Other analysts have also issued research reports about the company. Acumen Capital set a C$13.25 target price on Sylogist in a report on Friday, August 9th. Cormark upped their price target on Sylogist from C$12.25 to C$14.00 in a research report on Friday, August 9th. Finally, Ventum Cap Mkts upgraded Sylogist to a "strong-buy" rating in a research report on Tuesday, July 16th. Four research analysts have rated the stock with a buy rating and one has issued a strong buy rating to the company's stock. According to MarketBeat.com, the stock has a consensus rating of "Buy" and a consensus price target of C$12.96.

Read Our Latest Stock Report on Sylogist

Sylogist stock opened at C$10.57 on Monday. Sylogist has a fifty-two week low of C$6.51 and a fifty-two week high of C$11.60. The firm's 50 day simple moving average is C$11.02 and its 200-day simple moving average is C$10.35. The company has a debt-to-equity ratio of 53.47, a current ratio of 0.45 and a quick ratio of 0.51. The company has a market cap of C$246.81 million, a P/E ratio of 1,057.00 and a beta of 0.82.

Sylogist (TSE:SYZ - Get Free Report) last posted its quarterly earnings data on Thursday, August 8th. The company reported C($0.01) earnings per share (EPS) for the quarter, missing the consensus estimate of C$0.05 by C($0.06). Sylogist had a return on equity of 0.61% and a net margin of 0.34%. The company had revenue of C$17.40 million for the quarter, compared to analyst estimates of C$17.33 million.

The firm also recently declared a quarterly dividend, which will be paid on Sunday, December 29th. Stockholders of record on Wednesday, December 11th will be paid a dividend of $0.01 per share. The ex-dividend date of this dividend is Wednesday, December 11th. This represents a $0.04 annualized dividend and a dividend yield of 0.38%. Sylogist's dividend payout ratio (DPR) is 400.00%.

In related news, Director Taylor Gray sold 10,000 shares of the company's stock in a transaction on Tuesday, October 15th. The shares were sold at an average price of C$10.81, for a total value of C$108,100.00. 3.34% of the stock is owned by insiders.

Sylogist Ltd., a software company, provides mission-critical software-as-a-service solutions in Canada, the United States, and the United Kingdom. The company offers SylogistMission constituent relationship management system, which includes donor management, fundraising, volunteer management, and program delivery; and enterprise resource management, such as accounting and financial management, grant and award management, budget management, payroll and human resources, analytics and reporting, and support and training.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected].

Before you consider Sylogist, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sylogist wasn't on the list.

While Sylogist currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

Previous articleNext article

POPULAR CATEGORY

corporate

7774

tech

8836

entertainment

9699

research

4181

wellness

7532

athletics

9948